Critical Review of the Determination Process by the Japanese Reviewing Authority in Approving the Additional Efficacy of Fludarabine Phosphate
Narimatsu et al.
JCO 2009;27:e236-e238.
FULL TEXT
Going Off-label Without Venturing Off-Course: Evidence and Ethical Off-label Prescribing
Largent et al.
Arch Intern Med 2009;169:1745-1747.
FULL TEXT
Pharmacists' role in facilitating evidence-based prescribing for unlabeled use of medications
Macaulay et al.
Am J Health Syst Pharm 2009;66:1735-1739.
FULL TEXT
Off-Label Use of Antipsychotic Medications in the Department of Veterans Affairs Health Care System
Leslie et al.
Psychiatr. Serv. 2009;60:1175-1181.
ABSTRACT
| FULL TEXT
Off-label prescribing: a call for heightened professional and government oversight.
Dresser and Frader
J Law Med Ethics 2009;37:476-486.
Just a Spoonful of Sugar: Drug Safety for Pediatric Populations
Noah
J Law Med Ethics 2009;37:280-291.
Shifting Terrain in the Regulation of Off-Label Promotion of Pharmaceuticals
Mello et al.
NEJM 2009;360:1557-1566.
FULL TEXT
Systematic Review: Reliability of Compendia Methods for Off-Label Oncology Indications
Abernethy et al.
ANN INTERN MED 2009;150:336-343.
ABSTRACT
| FULL TEXT
Controlling Off-Label Medication Use
Gillick
ANN INTERN MED 2009;150:344-347.
ABSTRACT
| FULL TEXT
Commentary: Risk/Benefit Ratio of Androgen Deprivation Treatment for Sex Offenders
Berlin
J Am Acad Psychiatry Law 2009;37:59-62.
ABSTRACT
| FULL TEXT
Cardiac Resynchronization Therapy for Heart Failure: A Hammer in Search of Nails
McAlister
Circulation 2008;118:901-903.
FULL TEXT
Who Are the New Users of Antipsychotic Medications?
Domino and Swartz
Psychiatr. Serv. 2008;59:507-514.
ABSTRACT
| FULL TEXT
FDA Guidance on Off-Label Promotion and the State of the Literature From Sponsors
Psaty and Ray
JAMA 2008;299:1949-1951.
FULL TEXT
Pharmaceutical Promotion to Physicians and First Amendment Rights
Kesselheim and Avorn
NEJM 2008;358:1727-1732.
FULL TEXT
Regulating Off-Label Drug Use -- Rethinking the Role of the FDA
Stafford
NEJM 2008;358:1427-1429.
FULL TEXT
Gabapentin: a multimodal perioperative drug?
Kong and Irwin
Br J Anaesth 2007;99:775-786.
ABSTRACT
| FULL TEXT
Indication creep: physician beware
Hebert and Stanbrook
CMAJ 2007;177:697-697.
FULL TEXT
L'expansion des indications : medecins, attention
Hebert and Stanbrook
CMAJ 2007;177:699-699.
FULL TEXT
What Cannot Be Said on Television About Health Care
Emanuel
JAMA 2007;297:2131-2133.
FULL TEXT
Positive Outcomes Through the Appropriate Use of Off-Label Prescribing
Bright
Arch Intern Med 2006;166:2554-2555.
FULL TEXT
Safeguarding Patient Welfare: Who's In Charge?
Henney
ANN INTERN MED 2006;145:305-307.
FULL TEXT